Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Gisbert Auwaerter Insider Profile
4 Followers
Paul Gisbert Auwaerter, Director at Capricor Therapeutics, holds 5.00K shares in Capricor Therapeutics (Ticker: CAPR). Most recently, Paul Gisbert Auwaerter Bought $5,000 shares of Capricor Therapeutics on Oct 10, 2023 for an estimated value of 14.20K.
Paul Gisbert Auwaerter has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Paul Gisbert Auwaerter's holdings
Insider Roles
Director
Roles that Paul Gisbert Auwaerter holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paul Gisbert Auwaerter
Paul Gisbert Auwaerter's Trading History
List of latest transactions for each holding click on a transaction to see Paul Gisbert Auwaerter's performance on stock
You May Also Like
Paul Gisbert Auwaerter insider profile FAQ
What is the percentage of profitable transactions made by Paul Gisbert Auwaerter?
The percentage of profitable transactions made by Paul Gisbert Auwaerter is ―.
What is the average return per transaction made by Paul Gisbert Auwaerter?
The average return per transaction made by Paul Gisbert Auwaerter is ―.
What stocks does Paul Gisbert Auwaerter hold?
Paul Gisbert Auwaerter holds: CAPR stocks.
What was Paul Gisbert Auwaerter’s latest transaction?
Paul Gisbert Auwaerter latest transaction was an Informative Buy of $14.20K.
What was Paul Gisbert Auwaerter's most profitable transaction?
Paul Gisbert Auwaerter’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul Gisbert Auwaerter's role in Capricor Therapeutics?
Paul Gisbert Auwaerter's role in Capricor Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.